Penumbra Inc (PEN) Company Profile & Statistics

Penumbra Inc
PEN
(NYSE)
N/A
205.53
+1.12 (+0.55%)
in:usd•As of: Apr 29, 2024 12:33 UTC -4
Open
204.70
High
207.87
Low
203.90

About Penumbra Inc

CEO

Adam Elsesser

Headquarters

one penumbra place

alameda, ca 94502, united states

Auditor

Deloitte & Touche LLP

Employees

4,200

Share Holders

Website

www.penumbrainc.com

Industry

medical specialties

Sector

health technology

Company Overview

Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California.

Penumbra Inc Statistics

Valuation Measures

Market Capitalization ²	7.97B
Enterprise Value	7.82B
Enterprise Value/EBITDA (ttm)	77.62
Price to Earnings Ratio (ttm)	97.80
Price to Book (mrq)	6.69
Price to Sales (ttm)	7.48
Price to Cash (ytd)	72.29

Profitability

Gross Margin (ttm)	64.42%
Operating Margin (ttm)	7.74%
Profit Margin (ttm)	8.31%
Return on Equity (ttm)	7.49%
Return on Invested Capital (ttm)	7.88%
Return on Assets (ttm)	5.60%

Income Statement

Revenue (ttm)	1.06B
Revenue Per Share (ttm)	27.35
Gross Profit (ttm)	682.64M
EBITDA (ttm)³	100.81M
Net Income Avi to Common (ttm)	90.95M
Diluted EPS (ttm)	2.31

Share Statistics

Beta (5Y Monthly)	0.51
52-Week Change	-28.00%
S&P500 52-Week Change	26.13%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	38.70M
Dividend Yield	0.00%
Float ⁴	36.70M
% Held by Insiders	5.30%
% Held by Institutions	88.88%

Balance Sheet

Total Cash (mrq)	289.19M
Total Cash Per Share (mrq)	7.47
Total Debt (mrq)	25.91M
Total Debt/Equity (mrq)	2.20%
Current Ratio (mrq)	6.06%
Quick Ratio (mrq)	3.49%
Book Value Per Share (mrq)	30.48

Cash Flow

Operating Cash Flow Per Share (ytd)	2.48
Free Cash Flow (ytd)	81.13M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Penumbra Inc

Trade With A Regulated Broker